Literature DB >> 27465334

Gel-based chemical cross-linking analysis of 20S proteasome subunit-subunit interactions in breast cancer.

Hai Song1, Hua Xiong2, Jing Che3, Qing-Song Xi2, Liu Huang2, Hui-Hua Xiong2, Peng Zhang4.   

Abstract

The ubiquitin-proteasome system plays a pivotal role in breast tumorigenesis by controlling transcription factors, thus promoting cell cycle growth, and degradation of tumor suppressor proteins. However, breast cancer patients have failed to benefit from proteasome inhibitor treatment partially due to proteasome heterogeneity, which is poorly understood in malignant breast neoplasm. Chemical crosslinking is an increasingly important tool for mapping protein three-dimensional structures and proteinprotein interactions. In the present study, two cross-linkers, bis (sulfosuccinimidyl) suberate (BS(3)) and its water-insoluble analog disuccinimidyl suberate (DSS), were used to map the subunit-subunit interactions in 20S proteasome core particle (CP) from MDA-MB-231 cells. Different types of gel electrophoresis technologies were used. In combination with chemical cross-linking and mass spectrometry, we applied these gel electrophoresis technologies to the study of the noncovalent interactions among 20S proteasome subunits. Firstly, the CP subunit isoforms were profiled. Subsequently, using native/SDSPAGE, it was observed that 0.5 mmol/L BS(3) was a relatively optimal cross-linking concentration for CP subunit-subunit interaction study. 2-DE analysis of the cross-linked CP revealed that α1 might preinteract with α2, and α3 might pre-interact with α4. Moreover, there were different subtypes of α1α2 and α3α4 due to proteasome heterogeneity. There was no significant difference in cross-linking pattern for CP subunits between BS(3) and DSS. Taken together, the gel-based characterization in combination with chemical cross-linking could serve as a tool for the study of subunit interactions within a multi-subunit protein complex. The heterogeneity of 20S proteasome subunit observed in breast cancer cells may provide some key information for proteasome inhibition strategy.

Entities:  

Keywords:  breast cancer; chemical cross-linking; proteasome; protein-protein interaction; threedimensional gel electrophoresis

Mesh:

Substances:

Year:  2016        PMID: 27465334     DOI: 10.1007/s11596-016-1626-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  25 in total

1.  Different proteasome subtypes in a single tissue exhibit different enzymatic properties.

Authors:  B Dahlmann; T Ruppert; L Kuehn; S Merforth; P M Kloetzel
Journal:  J Mol Biol       Date:  2000-11-10       Impact factor: 5.469

2.  Characterization of the proteasome using native gel electrophoresis.

Authors:  Suzanne Elsasser; Marion Schmidt; Daniel Finley
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Mapping protein-protein interactions by mass spectrometry.

Authors:  Julian Vasilescu; Daniel Figeys
Journal:  Curr Opin Biotechnol       Date:  2006-07-05       Impact factor: 9.740

4.  Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities.

Authors:  Oliver Drews; Robert Wildgruber; Chenggong Zong; Ute Sukop; Mikkel Nissum; Gerhard Weber; Aldrin V Gomes; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2007-07-27       Impact factor: 5.911

Review 5.  Exploring proteasome complexes by proteomic approaches.

Authors:  Oliver Drews; Chenggong Zong; Peipei Ping
Journal:  Proteomics       Date:  2007-04       Impact factor: 3.984

6.  Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.

Authors:  Antonia Busse; Marianne Kraus; Il-Kang Na; Anika Rietz; Carmen Scheibenbogen; Christoph Driessen; Igor Wolfgang Blau; Eckhard Thiel; Ulrich Keilholz
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

Review 7.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Authors:  D Chen; M Frezza; S Schmitt; J Kanwar; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

8.  Purification and proteomic analysis of 20S proteasomes from human cells.

Authors:  Marie-Pierre Bousquet-Dubouch; Sandrine Uttenweiler-Joseph; Manuelle Ducoux-Petit; Mariette Matondo; Bernard Monsarrat; Odile Burlet-Schiltz
Journal:  Methods Mol Biol       Date:  2008

9.  Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes.

Authors:  Chenggong Zong; Glen W Young; Yueju Wang; Haojie Lu; Ning Deng; Oliver Drews; Peipei Ping
Journal:  Proteomics       Date:  2008-12       Impact factor: 3.984

Review 10.  The UPS: a promising target for breast cancer treatment.

Authors:  Ko Sato; Eeson Rajendra; Tomohiko Ohta
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

View more
  3 in total

1.  Antibiotic anisomycin induces cell cycle arrest and apoptosis through inhibiting mitochondrial biogenesis in osteosarcoma.

Authors:  Chuanhua Cao; Haiying Yu; Feng Wu; Huixiong Qi; Jingbo He
Journal:  J Bioenerg Biomembr       Date:  2017-11-21       Impact factor: 2.945

2.  Comparative gel-based proteomic analysis of chemically crosslinked complexes in dystrophic skeletal muscle.

Authors:  Sandra Murphy; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Electrophoresis       Date:  2018-04-20       Impact factor: 3.535

3.  LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.

Authors:  Murong Zhou; Yi Kong; Xiaobin Wang; Wen Li; Si Chen; Li Wang; Chengbin Wang; Qian Zhang
Journal:  Biomed Res Int       Date:  2021-02-26       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.